Cornerstone Advisors LLC Decreases Stock Position in CVS Health Corporation $CVS

Cornerstone Advisors LLC cut its holdings in CVS Health Corporation (NYSE:CVS) by 53.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,700 shares of the pharmacy operator’s stock after selling 18,100 shares during the quarter. Cornerstone Advisors LLC’s holdings in CVS Health were worth $1,184,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Avion Wealth boosted its position in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares during the last quarter. Harbor Capital Advisors Inc. boosted its holdings in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares during the last quarter. Corundum Trust Company INC bought a new stake in shares of CVS Health in the third quarter worth approximately $29,000. Front Row Advisors LLC raised its holdings in shares of CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new position in CVS Health during the second quarter valued at approximately $36,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Jefferies Financial Group increased their target price on CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. TD Cowen increased their price objective on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, December 10th. Wells Fargo & Company dropped their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a report on Thursday, November 13th. Finally, Argus reduced their target price on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Nineteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Trading Down 0.5%

Shares of CVS stock opened at $77.35 on Friday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The stock has a fifty day simple moving average of $78.58 and a two-hundred day simple moving average of $76.57. The firm has a market capitalization of $98.40 billion, a PE ratio of 56.05, a PEG ratio of 0.81 and a beta of 0.50. CVS Health Corporation has a 52-week low of $58.35 and a 52-week high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business’s quarterly revenue was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.